Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

@article{Dubois2007ResearchCF,
  title={Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria},
  author={Bruno Dubois and Howard H Feldman and Claudia Jacova and Steven T. DeKosky and Pascale Barberger‐Gateau and Jeffrey L. Cummings and André Delacourte and Douglas R. Galasko and Serge Gauthier and Gregory A. Jicha and Kenichi Meguro and John T. O'Brien and Florence Pasquier and Philippe H. Robert and Martin N. Rossor and Stephen P. Salloway and Yaakov Stern and Pieter Jelle Visser and Philip Scheltens},
  journal={The Lancet Neurology},
  year={2007},
  volume={6},
  pages={734-746}
}
New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist
TLDR
Four articles in the journal Alzheimer's and Dementia in 2011 describe new criteria for Alzheimer's disease dementia and mild cognitive impairment due to the AD pathophysiological process, providing more accurate and specific guidelines for the diagnosis of AD dementia and MCI due to AD.
Diagnosis and biomarkers of predementia in Alzheimer's disease
TLDR
The clinical characteristics of the prodromal and transitional states from normal cognitive ageing to dementia in AD are reviewed and the challenges and perspectives for the translation of research data into clinical practice are pointed out.
Biological diagnosis of Alzheimer’s disease and the issue of stigma
TLDR
A historical overview and ethical discussion about the conceptual changes in Alzheimer’s disease, from Alois Alzheimer to current era is offered.
When Does Alzheimer′s Disease Really Start? The Role of Biomarkers
TLDR
The role of biomarkers in the onset of AD is discussed, which is a step toward shifting the focus from the clinical symptoms to the biological alterations and toward changing the future diagnostic and treatment possibilities.
Biomarkers of Alzheimer's Disease: From Central Nervous System to Periphery?
TLDR
During the last decade, several neuroimaging and cerebrospinal fluid parameters have been introduced to allow an early and accurate detection of AD patients, and, recently, they have been included among research criteria for AD diagnosis, but their use in clinical practice suffers from limitations both in accuracy and availability.
Alzheimer’s diseases: towards biomarkers for an early diagnosis
TLDR
The clinical diagnosis performance for “probable AD” is relatively low with a sensitivity and a specificity of 80% and 70% respectively, and the clinical diagnosis specificity for a possible AD is less than 50%.
Evolution of the diagnostic criteria for degenerative and cognitive disorders.
TLDR
The new guidelines provide a definition of the dementia syndrome and core diagnostic features to be used in research and clinical practice, although they caution about the use of biomarkers, since they still require validation, and the longitudinal interaction and dynamics of these biomarkers in relationship to the manifestation of the symptoms are not fully understood.
...
...

References

SHOWING 1-10 OF 176 REFERENCES
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia
TLDR
NINCDS-ADRDA criteria fail accurately to differentiate AD from FTD, and suggestions to improve the diagnostic specificity of the current criteria are made.
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
TLDR
Baseline MRI measures of the entorhinal cortex, the banks of the superior temporal sulcus, and the anterior cingulate were most useful in discriminating the status of the subjects on follow‐up examination and provided information concerning the hierarchical fashion in which the pathology of AD may affect the brain during its prodromal phase.
Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II
TLDR
This cohort showed that comorbid conditions that can affect cognition delineate clearly defined subgroups in AD, and the presence of environmental or other brain disorders sufficient to produce dementia appears to affect physical survival in patients with AD, but not functional and cognitive decline or institutionalization.
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
TLDR
Criteria for the diagnosis of ischemic vascular dementia (IVD) broaden the conceptualization of vascular dementia, include the results of neuroimaging studies, emphasize the importance of neuropathologic confirmation, refine nosology, and identify areas that require further research.
Clinicopathologic Correlates in Alzheimer Disease: Assessment of Clinical and Pathologic Diagnostic Criteria
TLDR
Results show that the AD patients and control groups could be distinguished from each other easily on the basis of mean NP and NFT counts, but there was sufficient overlap in the counts to present difficulty in diagnosing any individual case.
Volumetric MRI Measurements Can Differentiate Alzheimer's Disease, Mild Cognitive Impairment, and Normal Aging
TLDR
The results suggest that measures of medial temporal lobe regions are useful to identify mild to moderate AD patients and MCI subjects, separating them from normal elderly individuals.
...
...